Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 10.21B | 12.74B | 4.96B | 2.78B | 2.72B | 1.72B |
Gross Profit | 6.97B | 7.28B | 3.92B | 2.14B | 2.04B | 1.42B |
EBITDA | 6.41B | 7.95B | 4.27B | 1.99B | 1.55B | 1.28B |
Net Income | 2.57B | 4.16B | 1.82B | 906.87M | 1.06B | 565.00M |
Balance Sheet | ||||||
Total Assets | 78.33B | 72.60B | 56.12B | 48.51B | 36.50B | 27.69B |
Cash, Cash Equivalents and Short-Term Investments | 2.68B | 2.58B | 3.02B | 1.19B | 1.81B | 509.22M |
Total Debt | 51.82B | 45.22B | 34.49B | 30.05B | 19.47B | 17.02B |
Total Liabilities | 59.23B | 53.46B | 40.50B | 34.50B | 22.62B | 18.48B |
Stockholders Equity | 19.10B | 19.15B | 15.62B | 14.01B | 13.88B | 9.21B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.24B | -4.99B | -13.43B | -7.70B | -7.68B |
Operating Cash Flow | 0.00 | 8.60B | 3.48B | -2.43B | 219.61M | -1.68B |
Investing Cash Flow | 0.00 | -14.56B | -5.89B | -9.19B | -5.46B | -5.66B |
Financing Cash Flow | 0.00 | 5.31B | 4.23B | 10.78B | 6.63B | 7.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥38.33B | 8.60 | 3.86% | 7.88% | 39.72% | ||
77 Outperform | ¥29.28B | 8.48 | 1.73% | 36.47% | 454.90% | ||
75 Outperform | ¥29.34B | 8.89 | 3.41% | 3.61% | -14.91% | ||
73 Outperform | ¥26.90B | 12.22 | 5.63% | 6.47% | -6.67% | ||
73 Outperform | ¥28.93B | 10.93 | 3.63% | -0.38% | 6.16% | ||
69 Neutral | ¥230.46B | 14.12 | 7.50% | 2.71% | 9.13% | 8.48% | |
56 Neutral | ¥33.27B | 484.06 | 6.08% | -46.16% | -98.25% |